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BM-40 (Osteonectin, SPARC) is the most abundant
glycoprotein secreted by human osteoblasts. In situ
hybridization studies on the expression of BM-40
mRNA in murine tissues have demonstrated the highest
levels of transcripts in bone, but expression was also
observed in several other mesenchymal tissues. In
contrast, little is known about the expression of BM-40
in human tissues, especially in skin. Total RNA obtained
from normal human skin was analyzed by northern
blotting and revealed a marked expression of BM-40.
To analyze its expression in vivo, in situ hybridization
was performed, demonstrating that BM-40 is expressed
in fibroblasts, smooth muscle, and endothelial cells in
the dermis. Interestingly, BM-40 mRNA was also
detected throughout the basal, spinous, and granular
The glycoprotein BM-40 (also termed SPARC, osteo-nectin) is a secreted protein widely distributed in humanand murine tissues. It has been identified in bone, whereit is one of the major noncollagenous glycoproteins, inbasement membranes, and in several other extracellular
tissues (Termine et al, 1981; Dziadek et al, 1986; Sodek, 1993). Several
studies describe high affinity binding to calcium (Engel et al, 1987;
Maurer et al, 1992) and calcium-dependent binding to various collagens
(Domenicucci et al, 1988; Sage et al, 1989b; Mayer et al, 1991; Nischt
et al, 1991; Kelm and Mann, 1991), as well as binding to hydroxyapatite
(Romberg er al, 1985) and platelet-derived growth factor (Raines et al,
1992) in vitro. In several cell culture studies using fibroblasts and
endothelial cells, BM-40 has been shown to influence the control of
cell shape, migration, growth control, and gene expression (for review,
see Lane and Sage, 1994; Reed and Sage, 1996).
Even though the exact biologic function is still unknown, BM-40
is expressed at high levels during tissue repair, differentiation, mouse
development, and growth, where it may act as an anti-adhesive factor
for cells (Holland et al, 1987; Sage et al, 1989a; Sage and Bornstein,
1991; Tremble et al, 1993; Reed et al, 1993). This suggests a versatile
function of BM-40 in the regulation of tissue synthesis and turnover,
including a major role as a morpho-regulatory element. Although
information regarding the structure and potential biologic functions of
BM-40 has increased significantly over the last few years, relatively
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layers in the epidermis of adult human skin. Further
analysis by immunohistochemistry revealed a marked
deposition in the dermis that was most intense directly
below the basement membrane in the papillary dermis
and around vascular as well as glandular structures.
In the epidermis, BM-40 protein could be detected
intercellularly in suprabasal layers. This finding is
further supported by the intercellular deposition of
BM40 detected by immunofluorescence in cultured
keratinocytes. This study demonstrates that BM-40 that
has previously been thought to be exclusively expressed
in extracellular matrix producing cells may in fact play
a role in differentiation and maintenance of the
epidermis. Key words: epidermis/extracellular matrix/
keratinocyte. J Invest Dermatol 110:122–126, 1998
little is known about the expression and distribution of BM-40 in
human tissues in vivo.
Therefore the aim of this study was to investigate BM-40 expression
and synthesis in adult human skin. We report here that BM-40 is
expressed in adult human skin in both the dermal and the epidermal
compartment, indicating a new role for BM-40 in epidermal differenti-
ation and growth in vivo.
MATERIALS AND METHODS
Tissue samples Normal skin was obtained from patients admitted for tattoo
excisions following informed consent. Specimens were bisected with one half
of the specimen undergoing routine paraffin processing and the other half being
snap frozen in liquid nitrogen and stored at –70°C until required.
Cell culture Human skin fibroblasts were obtained from normal human
skin using the explant culture technique. Primary keratinocyte cultures and
subcultures were established according to the method of Limat et al (1989).
The HaCaT cell line had been generously provided by Dr. N. Fusenig (DKFZ,
Heidelberg). HeLa cells were obtained from the American Type Culture
Collection (ATCC, Rockville, MD). The cells were grown to confluency in
monolayer cultures in Dulbecco’s modified Eagle medium, supplemented with
10% fetal calf serum, 50 mg ascorbate per ml, 300 mg glutamine per ml, 50 mg
streptomycin per ml, and 400 U penicillin per ml. Thereafter cells were
either subjected to RNA isolation or grown on glass slides for subsequent
immunohistochemical analysis.
Northern blot analysis Frozen skin biopsies were cut on dry ice and
homogenized in 4 M guanidine-isothiocyanate containing 0.1 M 2-mercapto-
ethanol. Alternatively cells were scraped from cell culture dishes using a
rubber policeman and dissolved in the same buffer. RNA was isolated by
ultracentrifugation over a cesium chloride cushion according to published
protocols (Maniatis et al, 1982). For northern blot analysis 5 mg total RNA was
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Figure 1. Comparison of BM-40 mRNA expression in vivo and in vitro.
(A) Total RNA isolated from normal skin (lane 1; 5 mg), fibroblasts (lane 2;
2 mg), and keratinocytes (lane 3; 5 mg) was separated on a 1% agarose gel,
blotted onto Genescreen, and hybridized with a 32P-labeled random primed
BM-40 cDNA probe as described in Materials and Methods. Hybridization
revealed strong signals in all three samples. (B) Methylen blue staining is shown
to confirm integrity and transfer of the RNA samples.
separated by gel electrophoresis in 1% agarose under denaturing conditions and
then blotted onto a nylon membrane (Genescreen, Dupont, Boston, MA). As
a control for the amount and integrity of RNA blotted, the membrane was
stained with methylene blue, 0.04% in 0.2 M sodium acetate (pH 5.2). Filters
were hybridized according to published protocols with 32P-labeled random
primed BM-40 cDNA probe. After hybridization filters were washed and
exposed at –80°C to a radiosensitive film (Kodak, X-Omat AR, Rochester, NY).
In situ hybridization Frozen 5 mm sections were investigated using the
nonradioactive in situ hybridization technique with digoxigenin labeled oligonu-
cleotides. The following anti-sense and sense 59 digoxigenin labeled oligonucleo-
tides corresponding to nucleotide position 136–169 were used (Lankat-
Buttgereit et al, 1988): anti-sense, 59-gctcccacagatacct-cagtcacctctgccacag-39;
sense, 59-Ctgtggcagaggtgac-tgaggtatctgtgggag-39. The specificity of these oligo-
nucleotides was confirmed by northern blot analysis of fibroblast total RNA
(not shown). Briefly, frozen sections were mounted on silane-coated slides and
fixed with 4% paraformaldehyde in phosphate-buffered saline for 5 min and
treated with 2 mg glycine per ml for 15 min thereafter. Prehybridization and
hybridization were performed at 42°C in a mixture containing 6 3 sodium
chloride/sodium citrate, 1 3 Denhardts solution, 100 mg tRNA per ml, 0.25%
sodium dodecylsulfate. After hybridization and washing in 6 3 sodium chloride/
sodium citrate at 42°C, digoxigenin-labeled probes were visualized as described
in the manufacturer’s protocol (Boehringer, Mannheim, Germany). Alternat-
ively, anti-sense and sense digoxigenin labeled riboprobes were prepared using
a 490-bp BM-40 cDNA fragment subcloned into the vector pBluescript
KS1 (Stratagene, La Jolla, CA) (Lankat-Buttgereit et al, 1988). The probes
were labeled with digoxigenin 11-UTP using a RNA labeling kit (Boehringer)
and hybridized in the same mixture with 50% formamide. After stringent
washings, sections were counter-stained with eosin or methyl green and
mounted.
Immunohistochemical staining Alkaline phosphatase anti-alkaline phos-
phatase staining was performed following established procedures (Schaumburg-
Lever, 1987). Rabbit anti-mouse immunoglobulins and alkaline phosphatase
anti-alkaline phosphatase complexes were obtained from Dako (Hamburg,
Germany). The alkaline phosphatase reaction was demonstrated by incubation
in a solution containing Fast Red TR (1 mg per ml) and naphtol AS-TR
phosphate (0.2 mg per ml) (Sigma, St. Louis, MO). Levamisole (0.24 mg per ml)
was added to block endogenous alkaline phosphatase activity.
Primary keratinocytes, HaCaT, and HeLa cells grown on glass slides were
stained using fluoroscein isothiocyanate conjugated goat anti-IgG antibodies
Figure 2. Increased BM-40 mRNA levels in keratinocytes after
induction of differentiation. To induce differentiation in cultured
keratinocytes the cells were cultivated in 3 mM sodium n-butyrate (lanes 4–6).
Untreated keratinocytes were used as controls (lanes 1–3). For RNA isolation
cells were harvested after 24 h (lanes 1, 4), 48 h (lanes 2, 5), and 72 h (lanes 3,
6). The RNA samples were separated in a 1% agarose gel, blotted onto
Genescreen, and hybridized to 32P-labeled BM-40 cDNA as described in
Materials and Methods. In the lower part methylen blue staining of rRNA is
shown to confirm even loading of the RNA samples.
Figure 3. Secretion of BM-40 protein by primary keratinocytes and
fibroblasts. Conditioned media from keratinocytes and fibroblasts were
analyzed by immunoblotting. The proteins were precipitated from the media
by trichloracetic acid and separated on a 10% sodium dodecylsulfate/
polyacrylamide gel under reducing conditions, transferred to nitrocellulose, and
incubated with BM-40 anti-serum as described in Materials and Methods. In
lane 1 0.5 ml of fibroblast conditioned medium was applied, and in lane 2 2 ml
of keratinocyte conditioned medium was applied. Calibration shown on the
right was with globular protein (kDa). BM-40 is detected as a single band of
about 42 kDa. The higher molecular bands are due to BM-40 aggregates
sometimes observed with cultivated cells.
following established protocols. In brief, after incubation with 1% normal
goat serum/1% bovine serum albumin in phosphate-buffered saline at room
temperature, the slides were incubated with the primary polyconal rabbit anti-
serum (Nischt et al, 1991) (diluted 1:400 in 1% normal goat serum/1% bovine
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Figure 4. BM-40 is localized in the periphery of keratinocytes with
suprabasal morphology. Primary human keratinocytes were grown on glass
slides for 72 h. The cells then were stained without fixation by
immunofluorescence with BM-40 anti-serum as described in Materials and
Methods. (A) Note the fluorescence at the cell–cell contact sites of keratinocytes
with suprabasal morphology; (B) staining of He La cells is shown as a negative
control. Scale bars, 35 µm.
serum albumin in phosphate-buffered saline) for 45 min. Incubation with the
secondary antibody (fluoroscein isothiocyanate conjugated goat anti-rabbit 1:400
in the same buffer) was carried out for 20 min. After washing and mounting
fluorescence microscopy was performed. Negative controls consisted of the
omission of primary antibodies, use of preimmune rabbit serum, and staining
with the dye alone. As a positive control a polyclonal antibody directed against
keratin was used. The stained sections were reviewed by two independent
observers.
Western blot analysis Trichloracetic acid precipitable proteins from serum
free culture medium (primary fibroblasts and keratinocytes) were resolved on a
10% sodium dodecylsulfate/polyacyrylamide gel under reducing conditions.
Thereafter proteins were transfered to nitrocellulose (Amersham, Braunschweig,
Germany). To block nonspecific antibody binding, the membrane was incubated
overnight in tris buffered saline containing 5% skimmed milk powder. Sub-
sequently the membrane was incubated with the polyclonal rabbit-anti-BM-40
Figure 5. Nonradioactive in situ hybridization of normal adult human
skin with BM-40 anti-sense and sense probes. In situ hybridization was
performed on consecutive skin sections using digoxigenin labeled
oligonucleotides. In (a) a section of normal human skin is shown after
hybridization with the anti-sense oligonucleotide, whereas in (b) the section is
shown after hybridization with the sense oligonucleotide (scale bars, 100 µm).
Note that BM-40 mRNA is present in the basal and suprabasal cell layers of
the epidermis. In (c) a higher magnification is shown. In the dermis BM-40
expression is found in fibroblasts (arrowheads) and perivascular areas (→) (scale
bar, 50 µm); in (d) BM-40 expression in smooth muscle cells is shown (scale
bar, 35 µm).
anti-serum diluted 1:2000. After washing, the membrane was incubated with
an horseradishperoxidase-conjugated swine anti-rabbit antibody (Dako) followed
by development using the ECL-system (Amersham).
RESULTS
Northern blot analysis of BM-40 in human skin compared with
cultured fibroblasts and keratinocytes It is known from several
in vitro studies that fibroblasts and keratinocytes are expressing BM-40
mRNA (Howe et al, 1990; Lankat-Buttgereit et al, 1991; Wrana et al,
1991; Ford et al, 1993). As BM-40 expression is usually induced when
attachment-dependent cells are grown on plastic, a phenomenon
referred to as ‘‘culture shock’’ (Sage et al, 1986; Lane and Sage, 1994),
we were interested to compare BM-40 mRNA levels in skin directly
with the levels expressed by keratinocytes and fibroblasts grown on
plastic. As shown in Fig 1, northern blot analysis revealed the usual
hybridization pattern for BM-40 mRNA in both fibroblasts and
keratinocytes, with a high level of the 2.2 kb and a lower level of the
3 kb transcript that contains additional 39 untranslated sequences
(Swaroop et al, 1988); however, in keratinocytes the level was markedly
lower when compared with fibroblasts (Fig 1, lanes 2 and 3). The
signal obtained with RNA isolated from skin biopsies is very strong,
indicating that the signals obtained with cultured keratinocytes and
fibroblasts reflect the BM-40 mRNA level in vivo, although we cannot
distinguish the cellular source of BM-40 mRNA in this experiment.
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Figure 6. Immunohistochemistry showing BM-40 deposition in human skin. Immunohistochemical staining for BM-40 protein using the alkaline anti-
alkaline phosphatase technique in adult human skin. Note (a) the pronounced staining in the papillary dermis and directly below the basement membrane zone
(scale bar, 100 µm) and (b) the intercellular staining in suprabasal cell layers (→) in the epidermis shown at higher magnification (scale bar, 35 µm).
Because it is known that BM-40 protein synthesis is increased in
human keratinocytes during sodium n-butyrate induced differentiation
(Staiano-Coico et al, 1989; Ford et al, 1993), we asked the question
whether the relatively low levels of BM-40 mRNA in keratinocytes
might be due to the nondifferentiating conditions used for RNA
isolation. To address this question keratinocytes were cultured in the
presence or absence of 3 mM sodium n-butyrate for 24, 48, and 72 h.
Northern blot analysis of RNA isolated from these cultures revealed a
dramatic increase of BM-40 mRNA in the sodium n-butyrate treated
keratinocytes already after 24 h when compared with untreated control
cells (Fig 2). This result clearly indicates that the elevated protein level
observed by Ford et al (1993) is due to an increase of the steady state
BM-40 mRNA level.
BM-40 synthesis and deposition in cultured fibroblasts and
keratinocytes In order to analyze BM-40 protein expression in
keratinocytes and fibroblasts, cells were grown to confluency in normal
growth medium and were subsequently cultivated for 48 h in serum-
free medium. Western blot analysis of these conditioned media show
that both cell types secrete BM-40 into the extracellular space (Fig 3).
In contrast to melanoma cells that show specific cleavage of BM-40
(Ledda et al, 1997), only one band of about 42 kDa was detected in
the supernatants of keratinocytes and fibroblasts.
Deposition of BM-40 was studied by indirect immunofluorescence
with the BM-40 polyclonal anti-serum on unfixed keratinocytes and
the keratinocyte-like cell line HaCaT (not shown) grown for 72 h on
coverslides. Under these culture conditions keratinocytes only show
signs of early differentiation. As seen in Fig 4(a), the most prominent
staining of BM-40 protein is detectable in the periphery of keratinocytes
with suprabasal morphology, suggesting that BM-40 is either associated
with the plasma membrane of these cells or secreted in the intercellular
space. This is in contrast to the observation of Ford et al (1993) who
found BM-40 deposition restricted to cornified envelopes. HeLa cells,
as a negative control cell line lacking BM-40 expression (Hafner et al,
1994), were negative (Fig 4b).
Localization of BM-40 mRNA and protein expression in human
skin by in situ hybridization and immunohistochemistry To
identify the cellular sources in the skin that are responsible for
the high BM-40 mRNA level obtained by northern blot analysis,
nonradioactive in situ hybridization using both digoxigenin labeled
oligonucleotides (Fig 5) or anti-sense and sense strand riboprobes
(results not shown) was performed. In the dermis expression was
detected in fibroblasts throughout the whole compartment as well as
in endothelial cells, smooth muscle cells, and glandular epithelial cells
(Fig 5a,c). In the epidermal compartment BM-40 mRNA expression
is seen throughout the epidermis, being partly more pronounced in
the basal cell layer (Fig 5a,b).
Immunohistochemistry with the BM-40 anti-serum revealed staining
in the whole dermal compartment, showing a clearly more pronounced
signal directly below the basement membrane and in the papillary
dermis (Fig 6a). This finding coincides with the increased density of
endothelial and fibroblast-like cells in the papillary dermis showing
BM-40 mRNA expression. An increase in staining intensity could also
be noted around vascular structures.
In the epidermis, staining for BM-40 was detected intercellularly
most prominently in the suprabasal spinous and to a lesser degree in
the basal and prickle cell layers (Fig 6b). No staining was detected in
the stratum corneum. This staining pattern clearly demonstrates that
BM-40 expression in vivo is not restricted to the cornified cell layers
of the epidermis.
DISCUSSION
Due to the origin of its purification, it had previously been assumed
that the expression of BM-40 is mainly restricted to connective tissue
and bone (Termine et al, 1981; Lankat-Buttgereit et al, 1988). As has
been implicated from several in vitro studies (Howe et al, 1990; Wrana
et al, 1991; Reed et al, 1993), BM-40 mRNA expression could be
detected in vivo in fibroblasts throughout the dermis, in endothelial,
smooth muscle and glandular epithelial cells. Increased deposition, as
shown by immunohistochemistry, seems thereby to take place in areas
supposedly characterized by an increased turnover of the surrounding
connective tissue, i.e., papillary dermis, perivascular areas, and adnexal
structures.
In the epidermis, as shown by in situ hybridization, the highest BM-
40 mRNA expression was detected in cells of the basal layer. This
indicates that the increase of BM-40 mRNA levels observed in sodium
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n-butyrate differentiated keratinocytes might be due either to a higher
expression rate or to stabilization of BM-40 mRNA mainly taking
place in basal keratinocytes after induction of the differentiation process.
In contrast, as shown by immunohistochemistry, there was no or only
little protein detectable in this layer, indicating either that BM-40
mRNA is mainly translated in suprabasal cells or that the protein is
readily deposited in a polarized fashion beneath the basal cell layer in
the basement membrane zone or above in the extracellular space of
the suprabasal cell layers. From our studies we cannot exclude that
BM-40 is also localized intracellularly as has been recently shown by
Porter et al (1995).
The role of BM-40 as an integral part of the epidermal intercellular
space is unclear. But it is intriguing to speculate that BM-40, which
has been classified as an ‘‘anti-adhesin’’ (Sage and Bornstein, 1991;
Lane and Sage, 1994), might be involved in the migration process
during epidermal differentiation by diminishing the contact of the basal
keratinocytes to the underlying basement membrane and cell–cell
contacts in the suprabasal layers. Whether BM-40, as a Ca21 binding
protein, is contributing to the Ca21 gradient in the epidermis (Forslind,
1987) is unknown, and it remains to be seen whether the EF-hands
in BM-40 fulfil a strictly structural role or whether they are used to
transmit a Ca21-coupled signal as seen in the cytosolic homologs of
the EF-hand family (for a review see Maurer et al, 1996).
Because BM-40 has been recently shown to be a substrate for
transglutaminase catalyzed cross-linking in differentiating cartilage
(Aeschlimann et al, 1995; Hohenadl et al, 1995), it is of interest to
point out that the expression pattern in skin of an antibody generated
to transglutaminase cross-links (Aeschlimann et al, 1995) parallels the
expression pattern in the skin described herein for BM-40. This
supports the possibility that BM-40 in the epidermis might be a target
for transglutaminase catalyzed cross-linking, thereby altering biologic
functions of this protein.
In summary, this study demonstrates that BM-40 is not only a
component of the connective tissue of different organs but also part
of epithelial structures such as the epidermis of adult human skin.
Because BM-40 is detected in different epithelial tumors (Porter et al,
1995; Bellahcene and Castronovo, 1995), an understanding of the
precise function of this protein in epithelial differentiation would also
provide insight into the role of BM-40 in processes underlying tumor
growth and invasion.
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